Back to Article
Mucormycosis and Candida Infections in Patients of COVID-19 Pneumonia: A Systematic Review
Global Journal of Epidemiology and Infectious Disease
| Vol 1, Issue 1
Table 1. Summary of the included studies
| Name of the Study | DOI | First Author |
| Candida auris outbreak in a COVID-19 specialty care unit—Florida, July–August 2020 | 10.15585/mmwr.mm7002e3 | Prestel, C. |
| Role of tocilizumab for concomitant systemic fungal infection in severe COVID-19 patient | 10.1097/MD.0000000000025173 | Anggraini Permata Sari |
| Increased incidence of candidemia in a tertiary care hospital with the COVID‐19 pandemic | 10.1111/myc.13225 | Nucci, M. |
| Epidemiology and Mycology of Candidaemia in non‐oncological medical intensive care unit patients in a tertiary center in the United States: Overall analysis and comparison between non‐COVID‐19 and COVID‐19 cases | 10.1111/myc.13258 | Macauley, P. |
| Post COVID-19 opportunistic candida retinitis: A case report | 10.4103/ijo.IJO_3047_20 | Bhagali, R., |
| Pulmonary Pathology of COVID-19 Following 8 Weeks to 4 Months of Severe Disease: A Report of Three Cases, Including One With Bilateral Lung Transplantation | 10.1093/ajcp/aqaa264 | Aesif, S.W. |
| Mixed mold infection with Aspergillus fumigatusand Rhizopus microsporus in a severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) patient | 10.1016/j.idnow.2021.01.010 | A.-P. Bellanger |
| Rhinocerebral Mucormycosis and COVID-19 Pneumonia | 10.14740/jmc3637 | Alekseyev, K. |
| Rare and Fatal Gastrointestinal Mucormycosis (Zygomycosis) in a COVID-19 Patient: A Case Report | 10.5946/ce.2020.180 | do Monte Junior ES |
| Coronavirus disease (Covid-19) associated mucormycosis (CAM): case report and systematic review of literature | 10.1007/s11046-021-00528-2 | Garg, D |
| Pulmonary aspergillosis and mucormycosis in a patient with COVID-19 | 10.1016/j.mmcr.2021.03.006 | Johnson, A.K. |
| A fatal case of Rhizopus azygosporus pneumonia following COVID-19 | 10.3390/jof7030174 | Kanwar, A. |
| Fulminant mucormycosis complicating coronavirus disease 2019 (COVID‐19) | 10.1002/alr.22785 | Karimi‐Galougahi, M. |
| Mucormycosis after Coronavirus disease 2019 infection in a heart transplant recipient–case report and review of literature | 10.1016/j.mycmed.2021.101125 | Khatri, A |
| Sino-orbital mucormycosis in a COVID-19 patient: A case report | 10.1016/j.ijscr.2021.105957 | Maini, A. |
| A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis. Infection | 10.1007/s15010-020-01561-x | Pasero, D. |
| Bronchopleural fistula development in the setting of novel therapies for acute respiratory distress syndrome in SARS-CoV-2 pneumonia | 10.1016/j.radcr.2020.09.026 | Placik, D.A. |
| COVID-19 triggering mucormycosis in a susceptible patient: a new phenomenon in the developing world? | 10.1136/bcr-2021-241663 | Revannavar, S.M. |
| 10.1007/s12070-021-02574-0 | Saldanha, M. | |
| Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: A case report. | 10.1177/11206721211009450 | Veisi, A. |
| A case of fatal rhino-orbital mucormycosis associated with new onset diabetic ketoacidosis and COVID-19 | 10.7759/cureus.13163 | Waizel-Haiat, S |
| Mucormycosis with orbital compartment syndrome in a patient with COVID-19 | 10.1016/j.ajem.2020.09.032 | Werthman-Ehrenreich, A. |
| The double-edged sword of systemic corticosteroid therapyin viral pneumonia: A case report and comparative reviewof influenza-associated mucormycosis versus COVID-19associated mucormycosis | 10.1111/myc.13256 | Kazem Ahmadikia |